Skip to main content

kidney diseases Archives

Kidney diseases research collaboration renewed

Oct. 6, 2022—Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

Read more


Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases

Sep. 11, 2017—Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.

Read more


Study tracks new end-stage renal disease therapy

Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.

Read more


Woman gives ultimate Valentine’s gift to her husband

Feb. 14, 2013—For the nearly 25 years Thomas Duncan has been married, he was crowned the king of Valentine’s Day gift giving. Not this year however, says his wife, Kim, who now carries the unofficial title after donating a kidney to her husband on Feb. 14. “We have definitely been joking about this,” chuckled Thomas Duncan before...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more